SNDL Q2 Earnings: Parallel Could Push Revenue Above US$1 Billion and Make It North America’s Largest Cannabis Retailer

SNDL’s second-quarter results offered two very different stories. Operationally, the company faced weaker demand across both its cannabis and liquor businesses, with profitability deteriorating throughout the income statement. Financially, however, SNDL continues to boast one of the strongest balance sheets in the cannabis industry, giving management flexibility to invest through the downturn.

By the Numbers

Revenue: C$235.8 million (-3.7% YoY)

Gross Profit: C$56.3 million (-16.6% YoY)

Gross Margin: 23.9% (down 3.7 percentage points)

Operating Income: Loss of C$7.8 million (vs. C$5.0 million profit in Q2 2025)

Adjusted Operating Income (EBIT): Loss of C$7.0 million (vs. C$5.8 million profit)

Net Income: Loss of C$7.8 million (vs. C$2.9 million profit)

Free Cash Flow: -C$6.7 million (improved from -C$7.9 million)

Change in Cash: -C$30.2 million, driven largely by C$23.5 million in share repurchases

Unrestricted Cash: C$183.2 million

Cash, Marketable Securities & Investments: C$598.5 million

Shares Repurchased: 11.7 million during Q2; more than 29 million shares repurchased since Q4 2024.

Margins Took the Biggest Hit

Revenue declined a relatively modest 3.7%, but profitability deteriorated much faster.

Gross profit fell 16.6%, reducing gross margin from 27.6% a year ago to 23.9%. The company also swung from an operating profit of C$5.0 million in the second quarter of 2025 to an operating loss of C$7.8 million, while adjusted operating income turned negative at C$7.0 million.

Net income also reversed course, moving from a C$2.9 million profit last year to a C$7.8 million loss this quarter.

Management attributed the weaker results to continued softness across both its liquor and cannabis businesses, combined with temporary production inefficiencies associated with the launch of Jeeter products.

“Our second quarter results reflect the impact of continued market softness across our core operating segments, as well as temporary production inefficiencies,” CEO Zach George said in a statement.

Cannabis Manufacturing Was the Weak Spot

The largest deterioration came from SNDL’s Cannabis Operations business.

Segment revenue declined 10.1%, but gross profit plunged 93.9%, falling from C$9.2 million to just C$567,000. Gross margin collapsed from 25.8% to 1.8%, while operating losses widened to C$9.2 million, reflecting weaker wholesale demand and production ramp-up costs related to Jeeter.

International cannabis sales provided one of the few bright spots, increasing from C$3.8 million to C$5.0 million year over year.

Cannabis Retail held up considerably better. Revenue slipped just 1.4%, while gross margin improved from 25.9% to 26.4%, demonstrating continued pricing discipline despite declining same-store sales in Alberta and Ontario.

The Balance Sheet Still Sets SNDL Apart

While operating performance weakened, SNDL continues to distinguish itself through capital allocation.

The company ended the quarter with C$183.2 million in unrestricted cash, no outstanding debt, and nearly C$600 million in total liquidity and investments.

During the quarter, management repurchased 11.7 million shares, bringing total buybacks to more than 29 million shares since late 2024.

The company also completed the restructuring of Parallel, a transaction expected to give SNDL direct control of medical cannabis operations in Florida, Texas and Massachusetts, adding 56 retail stores, three cultivation and manufacturing facilities and approximately US$150 million in annualized revenue once consolidated.

According to SNDL, the Parallel transaction has the potential to push the company above US$1 billion in annual revenue and make it the largest cannabis retailer in North America by store count, subject to the remaining closing and regulatory requirements.

“With 56 retail locations and three cultivation and manufacturing facilities, Parallel is expected to generate annualized revenue of approximately US$150 million in the near term. Combined with its accretive margin profile, this transaction positions SNDL as a leading vertically integrated cannabis operator, with the potential to exceed $1B in annual revenue and become the largest cannabis retailer in North America by store count,” reads the report.

Why It Matters

For investors, SNDL’s second quarter highlights an important distinction between financial strength and operating performance.

The operating business weakened across nearly every profitability metric that matters: gross profit, gross margin, operating income and net earnings all moved sharply lower. Those figures suggest that market softness and manufacturing inefficiencies continue to pressure earnings despite the company’s scale.

At the same time, SNDL remains one of the industry’s best-capitalized operators. With no debt, nearly C$600 million in liquidity and investments, an active share repurchase program and the pending integration of Parallel’s U.S. operations, management continues to prioritize long-term capital allocation over short-term earnings recovery.

Want to better understand how companies like SNDL are financing growth, allocating capital and structuring acquisitions?

Join us at Market Spotlight: Colorado 2026 on Friday, September 18, at the Westin Denver Downtown (1672 Lawrence St., Denver, CO), where executives, investors, lenders and dealmakers will break down the financial strategies shaping the next phase of the cannabis industry.